Metabolic Adaptation in Acute Ischemic Events: The Critical Role of Acyl‐Coenzyme A Synthetase Family in Myocardial Infarction and Ischemic Stroke
Open Access
- 16 June 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047469
Abstract
Acute ischemic events, such as myocardial infarction and ischemic stroke, are significant contributors to global morbidity and mortality. These pathological conditions, characterized by abrupt interruption of blood flow to critical tissues, induce substantial metabolic changes within affected tissues to maintain cellular viability under conditions of energy deprivation. ACSLs (acyl‐coenzyme A synthetase long‐chain family members) are key regulators of this metabolic adaptation, as they catalyze the conversion of long‐chain fatty acids into acyl‐coenzyme A thioesters, thereby affecting lipid metabolism, energy production, and cellular signaling pathways. Growing evidence highlights the crucial role of ACSLs in the pathophysiology of ischemic events because of their tightly regulated cell‐ and tissue‐specific responses to hypoxia, oxidative stress, and inflammation. In this review article, we explore the current literature on the molecular mechanisms by which ACSLs influence metabolic pathways, energy homeostasis, and cell fate determination during ischemia. Additionally, we evaluate whether ACSLs are promising therapeutic targets for reducing ischemic injury and promoting neuronal recovery. By understanding the complex interactions between ACSL activity and ischemic pathophysiology, this review article aims to identify ACSL research gaps, highlight new research directions, and explore novel therapeutic interventions for cardiovascular and neurological disorders.Keywords
This publication has 108 references indexed in Scilit:
- Targeting Acyl-CoA synthetase long-chain family member 4: a potential approach for the treatment of cerebral ischemia/reperfusion injuryMetabolic Brain Disease, 2025
- ACSL1 Aggravates Thromboinflammation by LPC/LPA Metabolic Axis in Hyperlipidemia Associated Myocardial Ischemia‐Reperfusion InjuryAdvanced Science, 2025
- The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approachesBasic Research in Cardiology, 2023
- Glucose transporters in brain in health and diseasePflügers Archiv - European Journal of Physiology, 2020
- Frontline Science: Acyl-CoA synthetase 1 exacerbates lipotoxic inflammasome activation in primary macrophagesJournal of Leukocyte Biology, 2019
- Interplay Between n‐3 and n‐6 Long‐Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and RepairLipids, 2017
- Activity‐dependent regulation of energy metabolism by astrocytes: An updateGlia, 2007
- Cerebrogenic cardiac arrhythmias:Clinical Autonomic Research, 2006
- Non‐syndromic X‐linked mental retardation: From a molecular to a clinical point of viewJournal of Cellular Physiology, 2005
- Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including manJournal of Molecular and Cellular Cardiology, 1992